The new Apple Creator Studio bundles the company's flagship creative software in a monthly subscription package for the first ...

Generation Z and Generation Alpha are reshaping beverage trends as they seek functional beverages that align with personal ...

CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Why AI’s real failure isn’t intelligence but memory and how broken continuity is quietly undermining advertising performance.

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...

Analyst/Investor Day January 29, 2026 8:00 AM ESTCompany ParticipantsCatherine Park - Vice President of Investor ...

Replacing Adobe without sacrificing features or editing power ...

Earn $35 an hour or more with these part-time jobs in health care, finance, and tech that let you work fewer hours without ...

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positiv ...

Detailed price information for Enliven Therapeutics Inc (ELVN-Q) from The Globe and Mail including charting and trades.

Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...